Ziopharm Oncology reported $0 in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Amgen AMGN:US $ 5327M 250M
AstraZeneca AZN:LN 9.61B 562M
Baxter International BAX:US $ 2473M 2M
Biogen BIIB:US $ 2003.5M 17.9M
Bioline Rx BLRX:US $ 0.19M 0.05M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Corcept Therapeutics CORT:US $ 28.16M 0.99M
Curis CRIS:US $ 2.4M 0.34M
Eleven Biotherapeutics EBIO:US 2.05M 22.44M
Gilead Sciences GILD:US $ 4118M 331M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Intercept Pharmaceuticals ICPT:US $ 27.52M 18.63M
Intrexon XON:US $ 0.56M 24.3M
Karyopharm Therapeutics KPTI:US $ 23.48M 1.51M
Novartis NOVN:VX 8.91B 232M
Ptc Therapeutics PTCT:US $ 135.94M 5.34M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sangamo Biosciences SGMO:US $ 6.29M 1M
Verastem VSTM:US $ 0.13M 2.51M
YTE INCY:US $ 682.97M 120.62M
Ziopharm Oncology ZIOP:US $ 0 1.11M